Clinical Trial Update: Notch Inhibitor in Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for a Notch inhibitor in advanced cancer; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Notch inhibitor

Snippet

Sponsor: Eli Lilly and Company | Conditions: Advanced Cancer | Phase 1 | Status: COMPLETED | Results posted: 2019-08-09